Cargando…
Intranasal Human Growth Hormone (hGH) Induces IGF-1 Levels Comparable With Subcutaneous Injection With Lower Systemic Exposure to hGH in Healthy Volunteers
CONTEXT: The development of an improved, efficacious human GH (hGH) product administered by a noninjectable route of delivery such as the nasal route is highly desirable. We have developed a novel nasal hGH product (CP024) that showed excellent nasal absorption in animal models; however, the transla...
Autores principales: | Lewis, Andrew L., Jordan, Faron, Patel, Tina, Jeffery, Kirk, King, Gareth, Savage, Martin, Shalet, Stephen, Illum, Lisbeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702464/ https://www.ncbi.nlm.nih.gov/pubmed/26425883 http://dx.doi.org/10.1210/jc.2014-4146 |
Ejemplares similares
-
What Factors Spur a Short Individual's Response to Human GH (hGH)?
por: Rogol, Alan D
Publicado: (2023) -
Adherence to r-hGH Therapy in Pediatric Growth Hormone Deficiency: Current Perspectives on How Patient-Generated Data Will Transform r-hGH Treatment Towards Integrated Care
por: Savage, Martin O, et al.
Publicado: (2022) -
Testosterone, cortisol, hGH, and IGF‐1 levels in an Italian female elite volleyball team
por: Roli, Laura, et al.
Publicado: (2018) -
Preclinical and Clinical In Vitro In Vivo Correlation of an hGH Dextran Microsphere Formulation
por: Vlugt-Wensink, K. D. F., et al.
Publicado: (2007) -
Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device
por: Loche, S., et al.
Publicado: (2016)